Razobazam
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
3,8-Dimethyl-4-phenyl-2,8-dihydropyrazolo[3,4-b][1,4]diazepine-5,7(4H,6H)-dione | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 78466-98-5 |
ATC code | None |
PubChem | CID 71228 |
UNII | LZ84VWN0U4 |
Chemical data | |
Formula | C14H14N4O2 |
Mol. mass | 270.28 g/mol |
SMILES
| |
(what is this?) (verify) | |
Razobazam (INN) is a drug which is a benzodiazepine derivative. Its mechanism of action appears to be quite different from that of most benzodiazepine drugs, and it produces nootropic effects in animal studies.[1]
See also
References
- ↑ Hock FJ, Scheich H. Functional activity in the brain of socially deprivated rats produced by an active avoidance test after razobazam (Hoe 175) treatment: a 2-deoxyglucose study. Behavioural and Neural Biology. 1986 Nov;46(3):398-409. PMID 3814045
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.